Brief: Medipharm Labs Australia Signs Second Gmp White-Label Deal
04/05/2020 13:26
May 4 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS AUSTRALIA SIGNS ITS SECOND GMP WHITE-LABEL
DEAL
TO SUPPLY NEW ZEALAND’S MEDICAL CANNABIS MARKET
* MEDIPHARM LABS CORP - TO SUPPLY PHARMACEUTICAL-QUALITY
WHITE-LABEL, CANNABIS OIL PRODUCTS TO CANNASOUTH PLANT RESEARCH
NEW ZEALAND
Source text for Eikon: ID:nGNX4v78jt
Further company coverage: LABS.TO
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue